Dr. Tendler[/caption]
Craig Tendler, M.D.
Vice President, Late-Stage Development and Global Medical Affairs for Oncology, Hematology and Supportive Care
Janssen Research & Development, LLC.
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Janssen announced the submission of a supplemental New Drug Application (sNDA) to the FDA seeking to expand the indication of ZYTIGA in combination with prednisone and androgen deprivation therapy (ADT) to include treatment of patients with high-risk metastatic hormone naïve prostate cancer (HNPC) or newly diagnosed, high-risk metastatic hormone sensitive prostate cancer (HSPC).
This submission is based on the pivotal Phase 3 LATITUDE trial results presented earlier this year at the plenary session of the American Society of Clinical Oncology (ASCO) Annual Meeting, which found that in patients with newly diagnosed high-risk metastatic hormone-sensitive prostate cancer (mHNPC), abiraterone acetate with prednisone in combination with androgen deprivation therapy (ADT) demonstrated a significant improvement in median overall survival (OS) and in radiographic progression-free survival (rPFS). Additional data, which were presented at the 2017 European Society for Medical Oncology (ESMO) Annual Conference, demonstrated clinically meaningful and statistically significant improvements in patient reported outcomes (PRO) in patients with high-risk mHNPC who received ZYTIGA in combination with prednisone and ADT compared to placebo plus ADT alone.
Prof. Davies[/caption]
Melanie J Davies CBE MB ChB MD FRCP FRCGP
Professor of Diabetes Medicine
NIHR Senior Investigator Emeritus
Diabetes Research Centre
Leicester Diabetes Centre – Bloom
University of Leicester
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: This was the first study to test the effectiveness of an oral GLP-1 in patients with type 2 diabetes.
The main findings were that compared to both placebo and a GLP-1, Semaglutide, delivered by sub-cutaneous injection weekly, the oral therapy delivered once a day produced better results than placebo and similar results to injectable GLP-1 with regard to reductions in HbA1c and weight loss.
Dr. Andreassi[/caption]
Dr. Maria Grazia Andreassi, PhD
Director, Genetics Research Unit
CNR Institute of Clinical Physiology, Pisa- Italy
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: In recent years, there has been a growing concern about the health risks for contemporary interventional cardiologists who have a high and unprecedented levels of occupational ionizing radiation (IR) exposure. Because dysregulation of microRNAs (miRNAs) have been shown in many human diseases, we investigated the differential expression of miRNAs in the plasma of interventional cardiologists professionally exposed to IR and unexposed controls.
In this study, our microarray analysis with 2,006 miRNAs and subsequent validation identified brain-specific miR-134 as one of the miRNAs that is highly dysregulated in the response to ionizing radiation exposure, supporting the notion that the brain damage is one of the main potential long-term risks of unprotected head irradiation in interventional cardiologists, with possible long-lasting cognitive consequences. Indeed, miR-134 was first identified as a brain-specific miRNA, which is involved in synapse development and directly implicated in learning and memory.
Dr. Dirlikov[/caption]
Emilio Dirlikov, PhD
Epidemic Intelligence Service Officer
CDC
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: In December 2015, Puerto Rico Department of Health (PRDH) reported its first confirmed locally acquired case of Zika virus disease. In February 2016, PRDH reported the first person diagnosed with Guillain-Barré syndrome (GBS) who also had evidence of Zika virus infection. At the time, scientific evidence of the potential association between Zika virus infection and GBS was lacking, and rigorous studies were needed.
Through a collaboration between PRDH, CDC, and the University of Puerto Rico (UPR), we conducted a case-control study to determine risk factors for GBS during the 2016 Zika virus epidemic. By prospectively enrolling case-patients, we shortened the time to enrollment, increasing the likelihood of detecting Zika virus nucleic acids to confirm Zika virus infection.
As a result, we found that an acute Zika virus infection confirmed by laboratory testing is a risk factor for developing Guillain-Barré syndrome. This is the first case-control study to find laboratory evidence showing this given the difficulty of confirming Zika virus infection among people diagnosed with GBS.
Prof. Durkin[/caption]
Maureen Durkin, PhD, DrPH
Professor and Interim Chair
Department of Population Health Sciences
University of Wisconsin School of Medicine and Public Health
Madison, WI
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Previous studies of the prevalence of autism spectrum disorder (ASD) among children in the U.S. have found two consistent patterns. One is a higher prevalence among white non-Hispanic children than among black non-Hispanic or Hispanic children. The other is a positive socioeconomic gradient, meaning that ASD prevalence in the U.S. is found to increase with increasing income and other indicators of socioeconomic status.
One of the findings of this new study is that the racial and ethnic differences in autism spectrum disorder prevalence are not explained by socioeconomic factors, because even after adjusting for socioeconomic factors, ASD prevalence was found to be significantly lower in black and Hispanic children than in white non-Hispanic children. Another finding is that the gap in ASD prevalence between children of high and low socioeconomic status did not change over time between 2002 and 2010, though the overall prevalence of ASD more than doubled during this period.
Dr. Masters[/caption]
Tamara Masters, PhD
Marketing
Marriott School of Management
Brigham Young University
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: As a marketing professor I have studied the disparity of what people are willing to sell items/products for and how much that differs from how much others are willing to pay.
I do research in consumer decision making and find the neurophysiological aspects of consumers fascinating. I read medical and neuroscience research for fun and see many ways individuals may be effected in the use of their limited resources. We are all consumers – many make purchases of some type daily – even it if it is to play online games or where and how to get our next meal.
The main findings relate to how a person is either attached to or feels an aversion to losing an object. There has been debate as to which of these factors leads to a difference in buy and selling prices. This research provides a new and unique look at how BOTH factors must be present for this disparity to emerge. This research is unique because it uses combines the fields neuroscience, psychology and economics to explain something we all experience.
Dr. Sung[/caption]
Dr. Hoon-Ki Sung MD PhD
Scientist at The Hospital for Sick Children (SickKids) and
Assistant Professor in Laboratory Medicine & Pathobiology
University of Toronto
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Despite extensive research and medical interventions, the prevalence of obesity and associated metabolic disease is increasing. More and more studies show that obesity and its associated metabolic problems are often associated with unhealthy lifestyles and eating habits, including frequent eating (non-stop) throughout the day, resulting in a shorter period of physiological fasting. As such, various dietary approaches, such as calorie restriction and intermittent fasting have gained popularity as therapeutic strategies for obesity treatment. Intermittent-fasting is when one temporarily stops eating for a period of time, returns to normal food consumption, and then temporarily stops again.
In our study we examined the effect of an intermittent-fasting regimen, without restricting caloric intake, in mice. We found that an intermittent fasting regimen not only prevented obesity in mice, but also improved metabolism by changing the quality of fat in the body.
Our findings show that the health of the mice is significantly influenced by daily eating patterns. The addition of a 'stop eating' period converted inflammatory fat to brown-like (or beige) fat by anti-inflammatory immune cells, meaning it changed bad fat into good fat.
The results are exciting, because they show that weight loss is not the sole benefit of fasting. Fasting also restores the dual function of fat cells, which is to store energy and to release energy.
Dr. Middelburg[/caption]
Rutger Middelburg, PhD
Assistant Professor in clinical epidemiology
Sanquin Research and LUMC
MedicalResearch.com: What is the background for this study?
Response: Six years ago we found transfusions from female donor to be associated with increased mortality among male recipients, especially under 50 years of age. This was an unexpected observation and we considered the probability of a false positive finding (i.e. a chance association) to be relatively high. We therefore immediately started a follow-up study with two main objectives. First, we wanted to confirm our findings in an independent and much larger cohort. Second, since some complications of blood transfusion are known to be related to pregnancy history of the donor, we wanted to study a possible relationship with previous pregnancy of the blood donors.
Dr. Vashi[/caption]
Neelam A. Vashi, MD
Assistant Professor of Dermatology
Director, Boston University Center for Ethnic Skin
Director, Cosmetic and Laser Center
Boston University School of Medicine
Boston Medical Center
[caption id="attachment_37525" align="alignleft" width="151"]
Dr. Maymone[/caption]
Mayra B. C. Maymone, MD, DSc.
Department of Dermatology
Boston University , Boston
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Societal interest with beauty dates back centuries; Plato described the 3 wishes of every man to include beauty, good health, and riches. Given this fascination, there are many people who have dedicated their entire lives to studying the concept of beauty and the implications it presents to society. The ability to set ‘beauty’ as a standard of comparison has shown us the advantages of being deemed beautiful – those who are more beautiful being able to get jobs easier and go out on more dates. Beautiful people are even more often attributed qualities such as likeability, social competence, and intelligence.
The study and concept of beauty are quite fascinating yet complicated. We have found that there are both biological/innate indicators and also subjective aspects. As discussed in my article, the classical conception of beauty is a matter of mathematical conceptions and instantiating definite proportions. However, this inflexible treatment of the concept of beauty as objective denies paying tribute to its many different aspects and the contributions of individuality, culture, and history. From our study, we can see that beauty standards are evolving and slowly drifting from the rigid standards once set. We found that compared to 1990, celebrities rated beautiful in 2017 were older, more often women, and had a higher rate of darker skin types and mixed race.
The study of beauty is a quite lengthy topic - I wrote a book on it: https://www.amazon.com/Beauty-Body-Dysmorphic-Disorder-Clinicians/dp/3319361988/ref=sr_1_2?ie=UTF8&qid=1508076953&sr=8-2&keywords=neelam+vashi.
Dr. Shin[/caption]
Thuzar M.Shin MD, PhD
Assistant Professor of Dermatology
Hospital of the University of Pennsylvania
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The Organ Procurement Transplant Network (OPTN) collects data on cancers that develop after organ transplantation. Previous studies have shown incomplete reporting to the OPTN for many cancers (including melanoma). Skin cancer is the most common malignancy in solid organ transplant recipients and the most common post-transplant skin cancer, cutaneous squamous cell carcinoma (cSCC), is not captured in standard cancer registries. We hypothesized that cSCC and melanoma are underreported to the OPTN. When compared to detailed medical record review obtained from the Transplant Skin Cancer Network database (JAMA Dermatol. 2017 Mar 1;153(3):296-303), we found that the sensitivity of reporting to the OPTN was only 41% for cSCC and 22% for melanoma. The specificity (99% for cSCC and 100% for melanoma) and negative predictive values (93% for cSCC and 99% for melanoma) were high. As a result, the OPTN database is unable to robustly and reliably distinguish between organ transplant recipients with and without these two skin malignancies.
Dr. Samba Reddy[/caption]
Dr. Samba Reddy, Ph.D., R.Ph., FAAPS, FAAAS, FAES
Professor
Neuroscience and Experimental Therapeutics
College of Medicine
Texas A&M University Health Science Center
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: For the past two decades, D. Samba Reddy, PhD, RPh, professor of neuroscience and experimental therapeutics at the Texas A&M College of Medicine, has been searching for answers to catamenial epilepsy, a subset of chronic epilepsy that causes a dramatic increase in seizures during women’s menstrual periods. Although this condition has been documented for millennia, there is currently no effective treatment for catamenial seizures, leaving many women and their families desperate for answers.
In this report, the researchers discovers the neuro-code for treating women with menstrual period-linked epilepsy. A unique platform has been created for clinical trials for catamenial seizures with synthetic neurosteroid agents.
Dr. Lucas[/caption]
Dr. Gale Lucas, PhD
Director of Research
USC Institute for Creative Technologies
Playa Vista, CA
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: A common barrier to healthcare for psychiatric conditions is the stigma associated with these disorders. Perceived stigma prevents many from reporting their symptoms. Stigma is a particularly pervasive problem among military service members, preventing them from reporting symptoms of combat-related conditions like posttraumatic stress disorder (PTSD).
This put them at risk for having their symptoms go untreated, with possible disastrous outcomes including suicide attempts. We envisioned a technology system – a virtual human interviewer – whereby military service members can get feedback about their risk for PTSD in a safe place without stigma. Indeed, our prior research has shown that, because its “just a computer” (therefore safe and anonymous), this virtual human interviewer helps people to feel safe discussing sensitive issues like mental health symptoms. In this follow-up research project (published in Frontiers), we sought to demonstrate the value of this kind of virtual human interviewer specifically for encouraging reporting of PTSD symptoms among service members.
Specifically, we were interested in comparing the willingness of service members to report symptoms of PTSD to our virtual human interviewer, compared to the gold standard of the Post Deployment Health Assessment (PDHA). We wanted to isolate the effect of anonymity, separating it from “relational factors” that the virtual human interviewer uses to encourage service members to open up. Indeed, before asking these same questions as on the PDHA to capture PTSD symptoms, the system engages in social dialogue, which build rapport with users. The system asks “get to know you questions,” and throughout the interview, engage in active listening with responses such as nods, smiles, saying “uh huh,” and other encouraging phrases like “that’s great.”
Dr. Zhang[/caption]
Cuilin Zhang MD, PhD
Senior Investigator
Epidemiology Branch
Division of Intramural Population Health Research
NICHD/National Institutes of Health.
Bethesda, MD 20817
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Gestational diabetes (GDM) is a common pregnancy complication. The American Heart Association identifies gestational diabetes as a risk factor for cardiovascular disease (CVD) in women, based on consistent evidence for the relationships between gestational diabetes and subsequent hypertension, dyslipidemia, type 2 diabetes, vascular dysfunction and atherosclerosis. Also, previous studies identify GDM as a risk factor for intermediate markers of CVD risk; however, few are prospective, evaluate hard cardiovascular disease end points, or account for shared risk factors including body weight and lifestyle.
Dr. Trudo[/caption]
Frank Trudo, MD, MBA
Brand Medical Lead US Respiratory
AstraZeneca
MedicalResearch.com: Would you tell us about Lungprint? How will Lungprint help asthma patients take better control of their disease?
Response: Lungprint is an interactive digital tool that creates a dynamic visual representation of a person’s lungs based on their unique experiences with asthma. It is meant to provide people with asthma a better understanding of the role of asthma in their life and motivate them to have a more personalized conversation with their healthcare provider about the severity of their symptoms, a more individualized treatment plan and a blood test that measures eosinophil levels.
Each person’s Lungprint, which is generated as they respond to a digital questionnaire about their experience with asthma, will help reveal information about their individual experience with asthma. You can visit www.lungprint.com to learn more about the tool and create your own Lungprint.
Dr. Mohajerani[/caption]
Abbas Mohajerani BsEng, MsEng, PhD, FIEAust, MAGS. MACI
Senior Lecturer
School of Engineering, Civil and Infrastructure Engineering
RMIT University
Melbourne Victoria Australia
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: I knew about the harmful chemicals in cigarette butts and was not happy to see them everywhere in the environment, in our footpath, parks, and rivers. Cigarette butts (CBs) contain a large number of toxic to highly toxic chemicals and stay in the environment for a long time. Decomposition of CBs can take from a couple of months to many years depending on the environmental factors.
Cigarette butts are one of the most common types of waste found around the world. Currently about 6 trillion cigarette butts per year are deposited somewhere in the environment. This is equivalent to an estimated mass of over 1.2 million tonnes of Cigarette butts each year. And this is expected to increase significantly by 2025, mainly due to an increase in the world population.
In 2005, I started to think about different ways to recycle CBs in construction materials, and the first idea which struck me was to recycle them in fired clay bricks.
After several years of research, we came up with a proposal, that if every brick manufacturer were to produce 2.5% of their bricks with 1% Cigarette butts incorporated, all CBs produced worldwide could be recycled. A 1% CB content would have very little effect on the physical and mechanical properties of the brick. And the estimated firing energy saved by incorporating 1% CBs into clay bricks is about 10%. That is a very significant reduction in the firing energy.
This proposal was published in the journal of Waste Management in May 2016.
Dr. Cash[/caption]
Brooks D. Cash, M.D., A.G.A.F., F.A.C.G., F.A.S.G.E.
Professor of Medicine and
Chief of the USA Gastroenterology Division
Director, Motility and Physiology Service
University of South Alabama
Mobile, Alabama
MedicalResearch.com: What is the background for this study?
Response: Irritable Bowel Syndrome (IBS) among patients with IBS-M (mixed diarrhea and constipation) is a challenging and difficult to diagnose and treat sub-type of IBS. Patients with IBS-M represent a dissatisfied group of IBS patients due to the lack of proven therapies. It is an area of high unmet medical need.
Among adult patients with IBS, a sizeable proportion suffers from IBS-M with prevalence rates estimated to be between 44 to 66 percent of IBS sufferers[1],[2],[3]. IBS-M patients carry a heavy burden, characterized by bouts of constipation interrupted by diarrhea and vice versa. Physicians find IBS-M challenging to manage because of the difficulty in avoiding ‘overshoots’ when diarrhea management can turn into constipation and vice versa.[4]
Dr. Schelfhout[/caption]
Dr. Jonathan Schelfhout, PhD
Director, Outcomes Research
Merck & Co. Inc.
North Wales, PA
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The cost of hematopoietic stem cell transplantation has received increased attention after it was identified as a top 10 contributor to increasing healthcare costs in an AHRQ 2016 report. Many recent studies have explored the cost of HSCT but additional research is needed on the costly complications that can follow the transplant procedure. This research is particularly relevant for inpatient decision makers, as most transplant centers receive one bundled payment for the transplant and the treatment of any complications over the first 100 days.
MedicalResearch.com Interview with: [caption id="attachment_37439" align="alignleft" width="125"] Dr. Danby[/caption] Dr. Simon G. Danby, PhD Independent Research Fellow Sheffield Dermatology Research, Department of Infection & Immunity & Cardiovascular Disease, Faculty of Medicine, Dentistry & Healthy, University of Sheffield UK MedicalResearch.com: What is the background for this study? What are the main findings? Response: Living in a hard water area has been...
Dr. Holzbauer[/caption]
Stacy Holzbauer, DVM, MPH, DACVPM
CDC Career Epidemiology Field Officer (CEFO)
Commander, USPHS
Minnesota Department of Health
St. Paul, MN
MedicalResearch.com: What is the background for this study?